Sutro Biopharma, Inc. (STRO)
NASDAQ·Healthcare·Biotechnology
$34.52
+2.77%
Mkt Cap $212.66M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $9.26M | $11.65M | +25.82% | -$8.16 | -$5.29 | +35.19% | — | — |
| Q4 2025 Nov 6, 2025 | $10.14M | $9.69M | -4.44% | -$4.20 | -$6.70 | -59.52% | — | — |
| Q3 2025 Aug 7, 2025 | $8.90M | $63.74M | +616.57% | -$0.39 | -$0.14 | +64.10% | — | — |
| Q2 2025 May 8, 2025 | $15.00M | $17.40M | +15.99% | -$0.63 | -$0.91 | -44.44% | — | — |
| Q1 2025 Mar 13, 2025 | $12.15M | $14.81M | +21.84% | -$0.86 | -$0.89 | -3.49% | — | — |
| Q4 2024 Nov 13, 2024 | $12.18M | $8.52M | -30.06% | -$0.74 | -$0.59 | +20.27% | — | — |
| Q3 2024 Aug 13, 2024 | $21.02M | $25.71M | +22.29% | -$0.76 | -$0.59 | +22.37% | — | — |
| Q2 2024 May 13, 2024 | $11.92M | $13.01M | +9.13% | -$0.92 | -$0.95 | -3.26% | — | — |
| Q1 2024 Mar 25, 2024 | $11.81M | $113.72M | +862.92% | -$0.82 | $0.42 | +151.22% | — | — |
| Q4 2023 Nov 13, 2023 | $11.81M | $16.92M | +43.30% | -$0.76 | -$0.81 | -6.58% | — | — |
| Q3 2023 Aug 10, 2023 | $12.56M | $10.41M | -17.10% | -$0.73 | -$0.64 | +12.33% | — | — |
| Q2 2023 May 15, 2023 | $12.13M | $12.67M | +4.47% | -$0.83 | -$0.76 | +8.43% | — | — |
| Q1 2023 Mar 30, 2023 | $11.15M | $8.63M | -22.58% | -$0.64 | -$0.61 | +4.69% | — | — |
| Q4 2022 Nov 8, 2022 | $35.71M | $25.15M | -29.59% | -$0.15 | -$0.37 | -146.67% | — | — |
| Q3 2022 Aug 8, 2022 | $16.01M | $28.10M | +75.54% | -$0.74 | -$0.55 | +25.68% | — | — |
| Q2 2022 May 9, 2022 | $10.46M | $5.90M | -43.62% | -$0.79 | -$0.84 | -6.33% | — | — |
| Q1 2022 Feb 28, 2022 | $11.81M | $10.65M | -9.81% | -$0.67 | -$0.83 | -23.88% | — | — |
| Q4 2021 Nov 10, 2021 | $8.52M | $8.52M | +0.00% | -$0.67 | -$0.67 | +0.00% | — | — |
| Q3 2021 Aug 9, 2021 | $28.05M | $28.05M | +0.00% | -$0.42 | -$0.13 | +69.05% | — | — |
| Q2 2021 May 7, 2021 | $13.19M | $14.66M | +11.11% | -$0.61 | -$0.43 | +29.51% | — | — |